Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for attenuation of ischemia-reperfusion injury in adult living donor liver transplantation
PACTR201512001367808Recruiting
- Sponsor
- National Liver Institute
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ketamine in ischemia-reperfusion injury (IRI) (2 arms), sponsored by National Liver Institute. Primary endpoint: Interleukin 6. Started Oct 2015; status: recruiting.
02
Drugs
ketamine
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on PACTR201512001367808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201512001367808.